Sort
4,870 grants matching “glp 1”
EXENDIN-4 IN INSULIN SECRETION AND SENSITIVITY IN DIABETES
$0Johns Hopkins University · M01 · FY2000 · RR
G protein mediated mechanisms of beta-cell compensation and failure in type 2 diabetes
$0Michelle E Kimple · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2025 · VA
Role of Nutrient Sensing Receptors for the Gut Microbiota in Metabolism
$0Brian Thomas Layden · Jesse Brown Va Medical Center · I01 · FY2025 · VA
Luminal factors affecting duodenal protection and chemosensing
$0Jonathan D. Kaunitz · Va Greater Los Angeles Healthcare System · I01 · FY2012 · VA
Physiologic and Molecular Mechanisms of Ventilator Induced Kidney Injury
$0Mark Lawrence Hepokoski · Va San Diego Healthcare System · I01 · FY2025 · VA
Regulation of insulin Secretion by the GLP-1 Receptor
$0David A. D'alessio · Durham Va Medical Center · I01 · FY2020 · VA
The role of the androgen receptor in insulin secretion
$0Franck Mauvais-Jarvis · Southeast Louisiana Veterans Health Care · I01 · FY2021 · VA
EFFECTS OF GLP ON GLUCOSE EFFECTIVENESS
$0Mayo Clinic Coll Of Medicine, Rochester · M01 · FY2000 · RR
Mechanisms of glucagon-like peptide 1 (GLP-1) in fatty liver disease
$0Frank A. Anania · Veterans Health Administration · I01 · FY2013 · VA
Comparative Effectiveness and Safety of Newer and Older Antihyperglycemic Medications
$0Ziyad Al-Aly · St. Louis Va Medical Center · I01 · FY2024 · VA
EFFECTS OF GLP 1 ON INSULIN ACTION IN DIABETIC &NON DIABETIC SUBJECTS
$0Mayo Clinic Coll Of Medicine, Rochester · M01 · FY2000 · RR
Neuroprotective And Neurorestorative Signaling Mechanism
$0Aging · Z01 · FY2004 · AG
Structural Functional Studies of CRLR and RAMPs 1 &2
$0Diabetes, Digestive, Kidney Diseases · Z01 · FY2005 · DK
CORE--PHARMACOKINETICS /PREFORMULATION
$0University Of Arizona · U19 · FY2001 · CA
CORE--TRANSLATION RESEARCH
$0University Of Pennsylvania · P01 · FY2001 · CA
Pharmacological Restoration of Diabetic Vascular Dysfunction
$0Jane E Reusch · Va Eastern Colorado Health Care System · I01 · FY2014 · VA
G Protein Mediated Mechanisms of Beta Cell Death Dysfunction and Decompensation in Diabetes
$0Michelle E Kimple · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2019 · VA
CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS
$0University Of Washington · P51 · FY2001 · RR
Metabolic regulation of islet hormone secretion in diabetes
$0Matthew J. Merrins · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2022 · VA
Regulation of insulin Secretion by the GLP-1 Receptor
$0David A. D'alessio · Durham Va Medical Center · I01 · FY2018 · VA
CORE--GENE AND CELLULAR THERAPY
$0University Of California Los Angeles · P30 · FY2001 · AI
Targeting Microvascular Contributors to Impaired Functional Exercise Capacity in Diabetes
$0Jane E Reusch · Va Eastern Colorado Health Care System · I01 · FY2019 · VA
Luminal factors affecting duodenal protection and chemosensing
$0Jonathan D. Kaunitz · Va Greater Los Angeles Healthcare System · I01 · FY2014 · VA
The role of the androgen receptor in insulin secretion
$0Franck Mauvais-Jarvis · Southeast Louisiana Veterans Health Care · I01 · FY2018 · VA
The impact of cholecystokinin on pancreatic beta-cell survival through paracrine and pharmacologic signaling
$0Dawn B Davis · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2024 · VA